Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis.

Lisman, Ton; Bernal, William; Adelmeijer, Jelle; Kamphuisen, Pieter-Willem; Bos, Sarah; Porte, Robert J

Lisman, Ton; Bernal, William; Adelmeijer, Jelle; Kamphuisen, Pieter-Willem; Bos, Sarah; Porte, Robert J.

Afiliação

Lisman T; Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Bernal W; Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Adelmeijer J; Liver Intensive Therapy Unit, Institute of Liver Studies, Kings College Hospital, Denmark Hill, London SE5 9RS, UK.
Kamphuisen PW; Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Bos S; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands and Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
Porte RJ; Department of Gastroenterology, Treant Hospital, Emmen, the Netherlands.

Res Pract Thromb Haemost ; 7(1): 100052, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36846648

Palavras-chave

anticoagulants; cirrhosis; end-stage liver disease; international normalized ratio; liver transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google